Alkermes
ALKS
#2133
Rank
C$13.03 B
Marketcap
C$78.18
Share price
4.26%
Change (1 day)
98.35%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2026 (TTM): C$0.32 Billion

According to Alkermes's latest financial reports the company's current earnings are C$1.56 Billion. In 2025 the company made an earning of C$0.43 Billion a decrease over its 2024 earnings that were of C$0.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.32 B-24.53%
2025 C$0.43 B-34.87%
2024 C$0.66 B-17.97%
2023 C$0.80 B-468.52%
2022 -C$0.22 Billion449.24%
2021 -C$39.87 Million-68.04%
2020 -C$0.13 Billion-52.1%
2019 -C$0.27 Billion64.49%
2018 -C$0.16 Billion-15.04%
2017 -C$0.19 Billion-34.2%
2016 -C$0.29 Billion-5.34%
2015 -C$0.3 Billion35084.97%
2014 -C$0.86 Million
2012 C$10.53 M-117.81%
2011 -C$59.17 Million-12.69%
2010 -C$67.77 Million94.3%
2009 -C$34.88 Million-117.7%
2008 C$0.19 B622.63%
2007 C$27.26 M
2004 -C$0.11 Billion-14.48%
2003 -C$0.13 Billion11.88%
2002 -C$0.12 Billion39.65%
2001 -C$80.71 Million5.73%
2000 -C$76.34 Million-28.91%
1999 -C$0.11 Billion237.28%
1998 -C$31.84 Million100.05%
1997 -C$15.92 Million-37.93%
1996 -C$25.64 Million82.72%
1995 -C$14.03 Million-26.79%
1994 -C$19.17 Million-72.78%
1993 -C$70.41 Million208.07%
1992 -C$22.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.87 B 10,852.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.40 B 6,554.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$15.03 B 4,364.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.87 B 3,128.65%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$13.62 B 3,945.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.81 B 6,082.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-C$0.31 Billion-189.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-C$0.39 Billion-214.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.22 B 857.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel